Bayer Aktiengesellschaft (ETR:BAYN) Shares Up 1% – Still a Buy?

Bayer Aktiengesellschaft (ETR:BAYN)’s stock price traded up 1% on Tuesday . The stock traded as high as €45.01 and last traded at €45.01. 2,452,552 shares traded hands during mid-day trading, The stock had previously closed at €44.56.

Bayer Aktiengesellschaft Stock Performance

The company has a market capitalization of $45.44 billion, a price-to-earnings ratio of -51.63, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97. The company has a 50-day moving average price of €37.97 and a 200-day moving average price of €31.30.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.